Back to 
ROYAL LONDON ASSET MANAGEMENT LTD
ROYAL LONDON ASSET MANAGEMENT LTD
CAPR
Showing 0 of 2 quarters
Position history for ROYAL LONDON ASSET MANAGEMENT LTD's holdings in Capricor Therapeutics, Inc.
No. Royal London Asset Management exited its CAPR (Capricor Therapeutics) position in Q4 2019. Its Q3 2019 13F listed 59,839 shares worth $2M. Royal London Asset Management first reported CAPR in Q3 2019 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.